Saturday 17 October 2026
Export VMD’s income statement to Excel — free account
Viemed Healthcare, Inc.
VMD Healthcare Medical Devices
Viemed Healthcare, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $270.3 million, up 20.5% from fiscal 2024. In the quarter to June 2026, revenue grew 23.9%, EPS fell 12.5%, free cash flow fell 18.2% and total debt rose 65.5%, each against the same quarter a year earlier. Revenue growth for three consecutive years.
9.48
0.27
−2.77%
Follow VMD
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
5 | 6 | 7 | 6 | 6 | 7 | 4 | 6 | — | — |
P/E ratio |
19.05 | 27.66 | 29.59 | 50.33 | 22.70 | 9.58 | 26.36 | 267,500.00 | 8.05 | 1,104,377.10 |
Altman Z-Score |
5.58 | 6.64 | 6.67 | 11.24 | 7.80 | 8.69 | 5.55 | — | — | — |
P/S ratio |
1.07 | 1.39 | 1.67 | 2.10 | 1.76 | 2.29 | 2.91 | 12,483.42 | 0.00 | 0.00 |
P/FCF ratio |
10.29 | 26.70 | 14.12 | 49.36 | 61.59 | 11.00 | 37.26 | 47,741.55 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
5.33 | 6.04 | 5.50 | 8.66 | 8.56 | 7.31 | 3.43 | 4.98 | 5.85 | 3.58 |
P/Operating CF |
15.67 | 20.74 | 23.07 | 37.98 | 23.82 | 51.92 | 31.60 | 99,293.81 | 0.00 | 0.00 |
Beneish M-Score |
(3.18) | (2.89) | (2.56) | (3.15) | (2.87) | 232.97 | (2.84) | (3.60) | (2.46) | — |
P/B ratio |
2.01 | 2.33 | 2.69 | 3.01 | 2.17 | 3.68 | 5.35 | 25,016.27 | 0.00 | 0.00 |
Price to Tangible BV |
3.47 | 3.12 | 3.67 | 3.01 | 2.17 | 3.68 | 5.35 | 25,016.27 | 0.00 | 0.00 |
EV/Sales |
1.07 | 1.33 | 1.64 | 1.99 | 1.57 | 2.12 | 2.90 | 3.55 | 3.55 | 3.55 |
EV/EBITDA |
5.84 | 7.12 | 8.19 | 11.86 | 8.46 | 9.24 | 14.91 | 17.66 | 17.66 | 17.66 |
EV/Operating CF |
5.54 | 7.61 | 6.65 | 9.93 | 8.17 | 7.92 | 12.20 | 13.60 | 13.60 | 13.60 |
EV/FCF |
10.25 | 25.54 | 13.86 | 46.61 | 54.91 | 10.18 | 37.11 | 31.59 | 31.59 | 31.59 |
Quick Ratio |
0.96 | 1.14 | 0.97 | 1.71 | 2.42 | 1.88 | 0.96 | 0.98 | 1.13 | 1.00 |
Current Ratio |
1.18 | 1.42 | 1.19 | 2.11 | 2.66 | 2.05 | 1.07 | 1.18 | 1.29 | 1.22 |
Net Debt/EBITDA |
(0.02) | (0.32) | (0.15) | (0.70) | (1.03) | (0.75) | (0.06) | (0.50) | 0.01 | 1.20 |
Debt/Assets |
6.22% | 2.26% | 4.65% | 0.59% | 5.13% | 7.46% | 15.03% | 6.41% | 13.77% | 26.30% |
Debt/Equity |
0.09 | 0.03 | 0.06 | 0.01 | 0.06 | 0.10 | 0.28 | 0.11 | 0.22 | 0.50 |
Asset Turnover |
1.44 | 1.35 | 1.35 | 1.18 | 1.02 | 1.35 | 1.18 | 1.41 | 1.51 | 0.99 |
Operating CF/Net income |
3.48 | 3.47 | 4.41 | 4.46 | 2.46 | 1.11 | 2.24 | 2.35 | 1.47 | 5.22 |
Capex/Depreciation |
(0.83) | (1.07) | (1.08) | (1.40) | (1.69) | (0.81) | (2.00) | (1.40) | (1.40) | 0.00 |
Interest Coverage |
17.31 | 20.84 | 35.09 | 38.62 | 32.72 | 40.28 | 29.36 | 56.25 | 32.44 | 2.37 |
| 10.79% | 9.11% | 9.71% | 6.48% | 10.34% | 50.29% | 22.35% | 33.77% | 44.75% | 6.59% | |
| 7.94% | 6.79% | 7.53% | 5.30% | 7.92% | 32.31% | 12.51% | 20.82% | 26.29% | 3.87% | |
ROIC |
8.98% | 8.44% | 8.59% | 5.88% | 8.97% | 21.68% | 13.48% | 24.86% | 23.14% | 0.00% |
Return on Tangible Assets |
17.32% | 12.27% | 12.83% | 7.02% | 9.88% | 39.80% | 15.04% | 27.90% | 33.31% | 7.82% |
Average Days of Receivables |
34.86 | 40.55 | 36.80 | 40.50 | 45.88 | 34.39 | 52.46 | 50.05 | 76.08 | 56.47 |
Research and Development Expense of Revenue |
1.12% | 1.37% | 1.52% | 1.94% | 1.80% | 0.82% | 1.06% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
48.28% | 50.16% | 51.22% | 52.84% | 51.29% | 43.95% | 56.40% | 57.41% | 54.10% | 74.06% |
Intangible Assets out of Total Assets |
0.30 | 0.19 | 0.20 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
3.38% | 2.80% | 3.20% | 3.75% | 4.40% | 3.72% | 4.84% | 4.19% | 1.76% | 0.00% |
Graham Net Nets |
(0.02) | 0.03 | (0.01) | 0.07 | 0.12 | 0.05 | (0.05) | 0.00 | 0.00 | 0.00 |
Graham Number |
5.69 | 4.74 | 4.25 | 2.91 | 3.53 | 6.20 | 2.48 | 2.27 | 0.00 | 0.00 |
Earnings Yield |
5.25% | 3.62% | 3.38% | 1.99% | 4.41% | 10.44% | 3.79% | 0.00% | 12.43% | 0.00% |
Free Cash Flow Yield |
9.72% | 3.74% | 7.08% | 2.03% | 1.62% | 9.09% | 2.68% | 0.00% | 0.00% | 0.00% |
Revenue per Share |
6.95 | 5.79 | 4.77 | 3.59 | 2.96 | 3.39 | 2.13 | 1.70 | 1.24 | 0.81 |
Operating CF per Share |
1.33 | 1.01 | 1.18 | 0.72 | 0.57 | 0.91 | 0.51 | 0.59 | 0.32 | 0.17 |
Capex per Share |
(0.61) | (0.71) | (0.61) | (0.56) | (0.48) | (0.20) | (0.34) | (0.14) | (0.09) | 0.00 |
Free Cash Flow per Share |
0.72 | 0.30 | 0.57 | 0.15 | 0.08 | 0.71 | 0.17 | 0.45 | 0.22 | 0.17 |
Cash per Share |
0.35 | 0.45 | 0.33 | 0.44 | 0.72 | 0.80 | 0.35 | 0.27 | 0.13 | 0.11 |
Shareholders Equity per Share |
3.69 | 3.44 | 2.97 | 2.51 | 2.40 | 2.11 | 1.16 | 0.86 | 0.63 | 0.34 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
3.69 | 3.44 | 2.97 | 2.51 | 2.40 | 2.11 | 1.16 | 0.86 | 0.63 | 0.34 |
Free Cash Flow |
28.08 | 11.64 | 21.71 | 5.91 | 3.35 | 27.32 | 6.28 | 17.07 | 8.45 | 6.29 |
Working Capital |
7.44 | 15.55 | 6.24 | 20.88 | 29.50 | 24.16 | 1.90 | 3.52 | 3.85 | 2.01 |
Capital Expenditures |
(23.83) | (27.45) | (23.50) | (21.83) | (19.15) | (7.79) | (12.81) | (5.30) | (3.57) | (1.64) |
Net Current Asset Value |
(7.14) | 9.11 | (2.63) | 19.79 | 24.17 | 16.31 | (11.09) | 2.01 | 3.05 | (0.60) |
EV/EBIT |
14.07 | 18.39 | 20.22 | 36.22 | 17.66 | 13.56 | 25.26 | 26.29 | 26.29 | 26.29 |
Capex to Sales |
0.09 | 0.12 | 0.13 | 0.16 | 0.16 | 0.06 | 0.16 | 0.08 | 0.08 | 0.00 |
Price to Operating Income |
14.13 | 19.22 | 20.60 | 38.36 | 19.81 | 14.67 | 25.36 | 74,154.08 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.37 | 0.34 | 0.30 | 0.23 | 0.18 | 0.17 | 0.12 | 0.12 | 0.12 | 0.10 |
Cash ROIC |
16.58% | 7.52% | 16.21% | 5.16% | 2.59% | 22.57% | 9.03% | 36.76% | 24.83% | 26.73% |
Accounts Receivable Turnover |
10.66 | 10.34 | 10.81 | 9.22 | 8.64 | 10.99 | 7.88 | 6.92 | 6.45 | 4.23 |
Accounts Payable Turnover |
18.15 | 19.17 | 20.56 | 18.39 | 16.36 | 15.07 | 4.58 | 3.60 | 3.20 | 1.97 |
Inventory Turnover |
24.52 | 20.35 | 17.12 | 17.96 | 18.31 | 27.90 | 11.42 | 7.38 | 7.55 | 4.66 |
Average Days of Payables |
23.31 | 21.33 | 21.73 | 17.86 | 27.08 | 14.94 | 70.74 | 128.69 | 100.37 | 207.17 |
Days of Inventory on Hand |
16.04 | 17.32 | 24.05 | 24.09 | 20.54 | 16.47 | 20.47 | 63.14 | 48.41 | 78.08 |
Average Receivables |
25.36 | 21.68 | 16.93 | 15.06 | 13.54 | 11.95 | 10.19 | 9.31 | 7.27 | 7.28 |
Average Payables |
6.33 | 4.75 | 3.42 | 2.94 | 2.67 | 3.40 | 5.29 | 4.64 | 3.85 | 3.86 |
Average Inventory |
4.68 | 4.47 | 4.10 | 3.02 | 2.38 | 1.84 | 2.12 | 2.26 | 1.63 | 1.63 |
Average Assets |
188.11 | 165.98 | 135.97 | 117.50 | 115.26 | 97.58 | 68.12 | 45.67 | 31.10 | 31.15 |
Average Common Equity |
138.41 | 123.60 | 105.49 | 95.96 | 88.26 | 62.70 | 38.14 | 28.16 | 18.27 | 18.30 |
Columns are period end dates